Prognostic importance of long-term SBP variability in high-risk hypertension

Pinto, Rita Del; Pietropaoli, Davide; Dobre, Mirela; Ferri, Claudio

doi:10.1097/hjh.0000000000002552

Cited by 8 publications

(6 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…BP variability (CV,%) is a predictor of CVD and mortality in the general population [ 28 ], so we also investigated the possible impact of CV on GF, but we did not find any. Ours results are in line with the results presented by Pagonas et al [ 27 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis

Pilecki,

Czarkowska-Pączek,

Lisik

et al. 2023

Ann Transplant

View full text Add to dashboard Cite

Background Hypertension is a risk factor for graft failure and mortality among kidney transplant recipients (KTRs). The aim of the study was to examine blood pressure (BP) as a factor that contributes to graft failure or death during a 10-year observation period. Material/Methods The study group comprised 70 KTRs who were treated according to their clinical state. Data were collected at 1 month and 1 year after transplantation and included office and ambulatory BP monitoring (ABPM) BP values, eGFR, proteinuria, and BMI. During the observation period, 6 patients died, and 10 lost the graft, but not during the first year. Results Office and ABPM BP values were within normal ranges and did not differ from each other. eGRF and BMI were higher at 1 year compared to 1 month after transplantation, and proteinuria decreased. Among those who died, DBP was lower compared to those of survivors with graft failure. Proteinuria and donor age were positively correlated with BP. Conclusions Monitoring of BP and adequate treatment of hypertension resulting in BP values within normal values among KTRs contribute to longer survival of the graft and recipient. Older donor age and proteinuria could predict post-transplant hypertension. Low diastolic BP of the recipient could increase the risk of death among KTRs. Despite the fact that ABPM is the blood pressure measurement method of choice, appropriate standard office measurement could also be used for BP monitoring.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis

Pilecki,

Czarkowska-Pączek,

Lisik

et al. 2023

Ann Transplant

View full text Add to dashboard Cite

show abstract

“…Finally, our aggregate analysis could not investigate the prognostic impact of more versus less intensive strategies across different strata of cardiovascular risk. Similarly, we could not assess the potential interactions between the intensity of BP control and long-term BP variability [52].…”

Section: Limitations Of the Studymentioning

confidence: 98%

Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis

Reboldi

Angeli

Gentile

et al. 2022

European Journal of Internal Medicine

View full text Add to dashboard Cite

“…— lack of awareness of doctors and patients that is needed to continue the therapy mostly for the rest of a patients’ lifetime [ 23 ];…”

Section: Struggle Formentioning

confidence: 99%

STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice

Filipiak,

Barrios,

Ferri

et al. 2023

Cardiol J.

View full text Add to dashboard Cite

The progress in pharmacotherapy that has been made in recent years, including the introduction of very effective and safe lipid-lowering and antihypertensive drugs, has not yet translated into the expected universal control of blood pressure, lipid disorders and diabetes. In the STRUGGLE FOR Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023, experts from five countries recounted several points about the paradigms of cardiological and cardiometabolic care for better control of classical modifiable risk factors in the year 2023. It is believed herein, that the need to intensify treatment, actively search for patients with cardiovascular risk factors, especially with arterial hypertension, hypercholesterolemia and diabetes, should go hand in hand with the implementation of the latest therapy, based on single pill combinations including proven, effective antihypertensive, lipid-lowering and antidiabetic molecules, many of which are listed in the present document. There is a need to use both new technological concepts, completely new drugs, as well as novel treatment concepts such as metabolic treatment in coronary artery disease, try to intensify the fight against smoking in every way, including the available range of drugs and procedures reducing the harm. This approach will provide substantially better control of the underlying cardiovascular risk factors in countries as varied as Italy, Poland, Spain, Uzbekistan and Vietnam.

show abstract

Prognostic importance of long-term SBP variability in high-risk hypertension

Cited by 8 publications

References 62 publications

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis

Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis

Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis

STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice

Contact Info

Product

Resources

About